Both in Pharmaceuticals
Viatris vs Roivant Sciences
Over the past year VTRS returned +83.2% and ROIV returned +92.4%; their daily moves had a correlation of 0.14.
VTRS +83.2% ROIV +92.4%Growth of $1, one year, split-adjusted
| Metric | VTRS | ROIV |
|---|---|---|
| Price | $19.22 | $38.23 |
| Market cap | $22.08B | $27.61B |
| Today | +1.59% | +6.08% |
| 1 month | +9.6% | +7.6% |
| 6 months | +20.5% | +32.7% |
| Year to date | +54.4% | +76.2% |
| 1 year | +82.5% | +95.1% |
| Revenue growth (YoY) | +4.9% | −33.5% |
| Gross margin | 38.8% | 100.0% |
| Net margin | −3.2% | −13164.8% |
| P/E (TTM) | — | — |
| Price / sales | 1.5× | 3,666.3× |
| Net cash | -$12.46B | $3.84B |
| Dividend yield | 2.50% | — |
| Volatility (60d) | 23.4% | 50.3% |
| Short % of float | 3.3% | 8.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).